The VIB organizes a symposium: 'Tumor Heterogeneity, Plasticity and Therapy (2nd edition)'.
Tumors are complex and evolving ecosystems composed of a wide variety of cell types, in addition to the cancer cells themselves. Increasing evidence indicates that the bi-directional interplay between tumor cells and their tumor microenvironment shape tumor evolution and therapy resistance.
Within a tumor, many cancer cells differ from each at the (epi-)genomic, transcriptional, and proteomic level, as well as phenotypically and functionally. Tumor heterogeneity represents a major hurdle for therapy, which may only target a subset of tumor cells. In addition, cancer cell plasticity permits rapid adaption to therapeutics and the development of tolerance and resistance, presenting additional challenges for both targeted and immunotherapies.
During this conference, a range of world leaders from academia and industry will discuss the latest developments in basic research, translational and clinical research, and therapeutic avenues.
Click here for registration and the program.
